Recently, high-throughput screening (HTS) has become the mainstream technique for drug
discovery. Compounds that are synthesized by combinatorial chemistry might be more …

Introduction: Glaucoma is a multifactorial optic neuropathy that can lead to progressive and
irreversible loss of vision. Today there are> 60 million glaucoma patients worldwide, and this …

PURPOSE: To evaluate the efficacy and safety of commercially available latanoprost
0.005% given every evening versus timolol 0.5% and dorzolamide 2% fixed combination …

Purpose To evaluate the safety and efficacy of the timolol/dorzolamide fixed combination
vslatanoprost 0.005% in exfoliation glaucoma patients. Methods We randomized in an …

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol
maleate 0.5% and dorzolamide 2%/timolol maleate 0.5% | Eye Skip to main content Thank …

OBJECTIVE: This study compared brimonidine with latanoprost as adjunctive therapy for the
treatment of open-angle glaucoma and ocular hypertension. BACKGROUND: Patients with …

Purpose To determine the efficacy and safety of bimatoprost given every evening versus the
dorzolamide/timolol fixed combination (DTFC) given twice daily in open-angle glaucoma …

BACKGROUND: Treatment of glaucoma is aimed at reducing intraocular pressure (IOP) to
prevent further damage to the optic nerve. For patients who do not respond to monotherapy …

OBJECTIVE: To compare the efficacy and safety of timolol 0.5%/dorzolamide 2% fixed
combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily. DESIGN …

US7642258B2 - Combination of brimonidine and timolol for topical ophthalmic use - Google
Patents US7642258B2 - Combination of brimonidine and timolol for topical ophthalmic use …